These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12825171)

  • 1. High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza.
    Shiraishi K; Mitamura K; Sakai-Tagawa Y; Goto H; Sugaya N; Kawaoka Y
    J Infect Dis; 2003 Jul; 188(1):57-61. PubMed ID: 12825171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Resistance to amantadine of epidemic strain of H3 subtype influenza virus: a primary study].
    Xu H; Qian Y; Xu H; Zhang JH; Zhu RN; Wang F
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):996-8. PubMed ID: 16759544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of amantadine-resistance influenza a (H3N2) in six prefectures, Japan, in the 2005-2006 season.
    Saito R; Li D; Suzuki Y; Sato I; Masaki H; Nishimura H; Kawashima T; Shirahige Y; Shimomura C; Asoh N; Degawa S; Ishikawa H; Sato M; Shobugawa Y; Suzuki H
    J Med Virol; 2007 Oct; 79(10):1569-76. PubMed ID: 17705168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of amantadine-resistant influenza A (H3N2) viruses in the 2005-2006 season and rapid detection of amantadine-resistant influenza A (H3N2) viruses by MAMA-PCR.
    Hata M; Tsuzuki M; Goto Y; Kumagai N; Harada M; Hashimoto M; Tanaka S; Sakae K; Kimura T; Minagawa H; Miyazaki Y
    Jpn J Infect Dis; 2007 Jul; 60(4):202-4. PubMed ID: 17642534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of amantadine-resistant influenza A virus isolated from 2001-02 to 2004-05 in Nara Prefecture.
    Kitahori Y; Nakano M; Inoue Y
    Jpn J Infect Dis; 2006 Jun; 59(3):197-9. PubMed ID: 16785705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reassortment between amantadine-resistant and -sensitive H1N1 influenza A viruses generated an amantadine-sensitive virus during the 2007-2008 season.
    Furuse Y; Suzuki A; Shimizu M; Kishi M; Sawayama R; Saito M; Fuji N; Nukiwa N; Oshitani H
    J Infect Dis; 2009 Dec; 200(11):1766-73. PubMed ID: 19874176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of amantadine-resistant influenza AH3 viruses isolated during the 2005-2006 winter season in Nara, Japan.
    Yoneda M; Inoue Y; Kitahori Y
    Jpn J Infect Dis; 2007 Feb; 60(1):53-4. PubMed ID: 17314428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of drug-resistant influenza virus: population dynamical considerations.
    Regoes RR; Bonhoeffer S
    Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amantadine- and oseltamivir-resistant variants of influenza A viruses in Thailand.
    Bai GR; Chittaganpitch M; Kanai Y; Li YG; Auwanit W; Ikuta K; Sawanpanyalert P
    Biochem Biophys Res Commun; 2009 Dec; 390(3):897-901. PubMed ID: 19850010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009.
    Choi WY; Kim S; Lee N; Kwon M; Yang I; Kim MJ; Cheong SG; Kwon D; Lee JY; Oh HB; Kang C
    Antiviral Res; 2009 Nov; 84(2):199-202. PubMed ID: 19720085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence and transmission of amantadine-resistant influenza A in a nursing home.
    Schilling M; Gravenstein S; Drinka P; Cox N; Krause P; Povinelli L; Shult P
    J Am Geriatr Soc; 2004 Dec; 52(12):2069-73. PubMed ID: 15571544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants.
    Ilyushina NA; Bovin NV; Webster RG; Govorkova EA
    Antiviral Res; 2006 Jul; 70(3):121-31. PubMed ID: 16516984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual mutations in the HA1 peptide of amantadine-resistant influenza viruses at positions 193 and 225.
    Inoue Y; Yoneda M; Kitahori Y
    Jpn J Infect Dis; 2007 May; 60(2-3):147-8. PubMed ID: 17515655
    [No Abstract]   [Full Text] [Related]  

  • 14. [Amantadine].
    Takeuchi Y
    Nihon Rinsho; 2003 Nov; 61(11):1967-74. PubMed ID: 14619440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Emergence of amantadine-resistant influenza A viruses].
    Tsuji K; Iwahashi J; Imamura Y; Yoshimoto S; Kajiwara J; Ishibashi T; Mori R; Yamada T; Toyoda T
    Uirusu; 2001 Dec; 51(2):135-41. PubMed ID: 11977753
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influenza virus of seasonal influenza , high increase of resistance to amantadine and rimantadine].
    Nau JY
    Rev Med Suisse; 2006 Jan; 2(50):308. PubMed ID: 16503051
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of amantadine-resistant H5N1 avian influenza variants in Asia.
    Cheung CL; Rayner JM; Smith GJ; Wang P; Naipospos TS; Zhang J; Yuen KY; Webster RG; Peiris JS; Guan Y; Chen H
    J Infect Dis; 2006 Jun; 193(12):1626-9. PubMed ID: 16703504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential patterns of amantadine-resistance in influenza A (H3N2) and (H1N1) isolates in Toronto, Canada.
    Higgins RR; Eshaghi A; Burton L; Mazzulli T; Drews SJ
    J Clin Virol; 2009 Jan; 44(1):91-3. PubMed ID: 19019729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
    Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
    Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.